- Home
- OPFI vs SMTI Comparison
OPFI vs SMTI Comparison
Compare OPFI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- SMTI
- Stock Information
- Founded
- OPFI 2009
- SMTI 1982
- Country
- OPFI United States
- SMTI United States
- Employees
- OPFI N/A
- SMTI 141
- Industry
- OPFI Finance: Consumer Services
- SMTI Medical/Dental Instruments
- Sector
- OPFI Finance
- SMTI Health Care
- Exchange
- OPFI Nasdaq
- SMTI Nasdaq
- Market Cap
- OPFI 343.1M
- SMTI 251.6M
- IPO Year
- OPFI N/A
- SMTI N/A
- Fundamental
- Price
- OPFI $9.63
- SMTI $29.37
- Analyst Decision
- OPFI Buy
- SMTI Strong Buy
- Analyst Count
- OPFI 2
- SMTI 2
- Target Price
- OPFI $11.75
- SMTI $50.00
- AVG Volume (30 Days)
- OPFI 883.3K
- SMTI 22.8K
- Earning Date
- OPFI 10-29-2025
- SMTI 11-12-2025
- Dividend Yield
- OPFI 10.75%
- SMTI N/A
- EPS Growth
- OPFI N/A
- SMTI N/A
- EPS
- OPFI N/A
- SMTI N/A
- Revenue
- OPFI $320,831,000.00
- SMTI $97,241,894.00
- Revenue This Year
- OPFI $118.17
- SMTI $24.49
- Revenue Next Year
- OPFI $11.29
- SMTI $14.43
- P/E Ratio
- OPFI N/A
- SMTI N/A
- Revenue Growth
- OPFI 31.26
- SMTI 34.29
- 52 Week Low
- OPFI $4.78
- SMTI $23.53
- 52 Week High
- OPFI $17.73
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- OPFI 39.30
- SMTI 42.27
- Support Level
- OPFI $9.19
- SMTI $28.00
- Resistance Level
- OPFI $10.45
- SMTI $30.99
- Average True Range (ATR)
- OPFI 0.43
- SMTI 1.34
- MACD
- OPFI -0.14
- SMTI -0.31
- Stochastic Oscillator
- OPFI 18.83
- SMTI 19.57
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.